US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and overdose risks associate ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly grow ...

The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

FDA Approves First New Non-Opioid Pain Pill in Decades By India Edwards HealthDay Reporter FRIDAY ... The new pill, developed ...

DelveInsight's Airway Clearance Devices for Cystic Fibrosis Market Insights report provides the current and forecast market analysis, indiv ...

Pleas note: we will be discontinuing the Global Markets Report after 28 February. Australian shares are set to open lower, ...

Twelve women made the list, led by Reshma Kewalramani of Vertex Pharmaceuticals ... most influential woman of Indian origin. Also Read India ranks third globally with 67 unicorns; fintech ...

First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management Journavx is the first drug to be approved in this new class ...